公司概覽
業務類別 Biotechnology
業務概覽 Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
公司地址 2525 East North Carolina Highway 54, Durham, NC, USA, 27713
電話號碼 +1 919 313-9633
傳真號碼 --
公司網頁 https://www.humacyte.com
員工數量 220
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Yang Cao Chief Regulatory Officer -- 29/04/2025
Mr. Shamik J. Parikh Chief Medical Officer -- 29/04/2025
Mr. Dale A. Sander Principal Accounting Officer, Chief Financial Officer, Chief Corporate Development Officer and Treasurer 美元 505.75K 29/04/2025
Dr. Laura E. Niklason, M.D.,PhD President, Chief Executive Officer and Director 美元 612.40K 29/04/2025
Dr. Heather Prichard Chief Operating Officer 美元 468.40K 29/04/2025
Mr. William John Scheessele Chief Commercial Officer -- 29/04/2025
 
董事會成員
董事會 職務 更新日期
Dr. John P. Bamforth Independent Director 29/04/2025
Mr. Brady W. Dougan Director 29/04/2025
Mr. Todd M. Pope Independent Director 29/04/2025
Ms. Kathleen Sebelius Chairman of the Board 29/04/2025
Dr. Susan Richards Windham-Bannister, PhD Independent Director 29/04/2025
Mr. Michael T. Constantino Independent Director 29/04/2025
Dr. Keith Anthony Jones, M.D. Independent Director 29/04/2025
Ms. Diane Seimetz, PhD Independent Director 29/04/2025
Dr. Laura E. Niklason, M.D.,PhD President, Chief Executive Officer and Director 29/04/2025
Dr. Emery N. Brown, M.D.,PhD Independent Director 29/04/2025
Dr. Max Wallace, J.D. Independent Director 29/04/2025
Mr. C. Bruce Green, M.D. Independent Director 29/04/2025
 
所屬ETF (更新日期: 07/03/2026 04:28)
代號 名稱 佔比% 持有日期
IBBiShares Biotechnology ETF0.62%28/02/2026
SCHASchwab US Small-Cap ETF™0.38%28/02/2026
VTWOVanguard Russell 2000 ETF0.38%31/01/2026
VHTVanguard Health Care ETF0.25%31/01/2026
IWCiShares Micro-Cap ETF0.21%28/02/2026
IWOiShares Russell 2000 Growth ETF0.14%28/02/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.08%28/02/2026
VTWVVanguard Russell 2000 Value ETF0.04%31/01/2026
SCHBSchwab US Broad Market ETF™0.04%28/02/2026
VTWGVanguard Russell 2000 Growth ETF0.01%31/01/2026
QQQXNuveen NASDAQ 100 Dynamic Overwrite0.01%30/11/2025
IBBQInvesco Nasdaq Biotechnology ETF0.01%27/02/2026
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
UWMProShares Ultra Russell20000.005%27/02/2026
URTYProShares UltraPro Russell20000.005%27/02/2026
BIBProShares Ultra Nasdaq Biotechnology0.004%27/02/2026
ITWOProShares Russell 2000 High Income ETF0.003%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.002%28/02/2026
HDGProShares Hedge Replication0.0001%27/02/2026
CBSEClough Select Equity ETF<0.000001%22/01/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.